Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The financing will support advancement of Radar’s internal programs including, programmable genetic and mRNA-based therapeutics that use RNA sensors for autoimmune diseases.
Lead Product(s): mRNA-based Therapy
Therapeutic Area: Immunology Product Name: Undisclosed
Highest Development Status: ApprovedProduct Type: Large molecule
Partner/Sponsor/Collaborator: NfX Bio
Deal Size: $13.4 million Upfront Cash: Undisclosed
Deal Type: Financing May 23, 2024